P-Sulfonatocalix[4]arene

Mahsima Heydari1, Najmeh Salehi2, Reza Zadmard3

  • 1Bioprocess Engineering Department, National Institute of Genetic Engineering and Biotechnology (NIGEB) Tehran Iran a.norouzy@nigeb.ac.ir.

RSC advances
|October 16, 2024
PubMed
概括

一个新的,FAM-Y4R4,最初是聚合的,但使用p-sulfonatocalix[4]arene (CX4) 得到了改进. 这种修改后的有效地将药物输送到细胞中,显示出对癌症治疗和药物开发的希望.